Task Force, Members; Committee for Practice Guidelines (CPG), ESC; National Cardiac Societies, ESC (2019). 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis, 290, pp. 140-205. Elsevier 10.1016/j.atherosclerosis.2019.08.014
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
1-s2.0-S0021915019314595-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (6MB) | Request a copy |
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology |
ISSN: |
0021-9150 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Nadia Biscozzo |
Date Deposited: |
08 Dec 2020 16:57 |
Last Modified: |
11 Dec 2020 01:28 |
Publisher DOI: |
10.1016/j.atherosclerosis.2019.08.014 |
PubMed ID: |
31591002 |
Additional Information: |
Konstantinos C. Koskinas: Task Force |
Uncontrolled Keywords: |
Apolipoprotein B Cholesterol; Dyslipidaemias Familial hypercholesterolaemia Guidelines High-density lipoproteins Lipoprotein remnants Lipoprotein(a) Low-density lipoproteins Total cardiovascular risk Treatment (adherence) Treatment (drugs) Treatment (lifestyle) Triglycerides Very low-density lipoproteins |
BORIS DOI: |
10.7892/boris.149346 |
URI: |
https://boris.unibe.ch/id/eprint/149346 |
Actions (login required)
 |
Edit item |